Table 2.

Laboratory clinical data of patients undergoing calcium acetate (CA) or sucroferric oxyhydroxide (SFO) as phosphate-binding agent

Laboratory parameter	CA	SFO
Ferritin, ng/ml
Basal	1451.8 ± 1299.3	1185.1 ± 268.2
4 weeks	1670.4 ± 1326.9	1166.0 ± 187.2
12 weeks	1722.2 ± 1622.0	1056.8 ± 327.9
20 weeks	1691 ± 1557.1	1149.8 ± 360.0
Transferrin saturation, %
Basal	29 ± 8.9	53.1 ± 29.4
4 weeks	43.4 ± 19.7	46.7 ± 28.9
12 weeks	38.8 ± 19.3	41.4 ± 18.6
20 weeks	32.4 ± 14.0	42.0 ± 15.6
Calcium, mg/dl
Basal	9.34 ± 0.3	9.1 ± 0.3
4 weeks	9.24 ± 0.3	8.9 ± 0.4
12 weeks	9.02 ± 0.5	8.7 ± 0.7
20 weeks	10.06 ± 0.7	8.9 ± 0.5*
Phosphate, mg/dl
Basal	5.16 ± 2.1	4.4 ± 2.2
4 weeks	4.88 ± 1.4	4.4 ± 1.8
12 weeks	4.42 ± 1.7	5.5 ± 2.7
20 weeks	3.26 ± 0.8	4.7 ± 2.9
Parathormone, pg/ml
Basal	242.1 ± 182.7	216.9 ± 259.2
4 weeks	309.4 ± 211.2	244.1 ± 267.7
12 weeks	327.1 ± 196.9	254.5 ± 380.9
20 weeks	181.5 ± 136.8	134.4 ± 108.8
C-reactive protein, mg/ml
Basal	16.9 ± 20.6	4.2 ± 2.6
4 weeks	12.02 ± 6.0	5.6 ± 7.0
12 weeks	12.54 ± 7.3	4.4 ± 3.9
20 weeks	7.78 ± 6.3	4.2 ± 1.7
Sedimentation velocity, mm
Basal	51.4 ± 24.2	45.3 ± 19.1
4 weeks	46.8 ± 24.2	39.2 ± 18.3
12 weeks	61.6 ± 26.9	26.4 ± 17.6*
20 weeks	47.6 ± 7.2	38.4 ± 19.4
Albumin, g/l
Basal	39.04 ± 2.2	35.7 ± 3.0
4 weeks	37.54 ± 1.6	35.4 ± 2.4
12 weeks	37 ± 3.7	33.9 ± 4.0
20 weeks	39.5 ± 1.8	32.8 ± 2.3*
Hemoglobin, g/dl
Basal	11.26 ± 0.9	10.9 ± 1.4
4 weeks	11.42 ± 0.8	10.1 ± 2.9
12 weeks	10.14 ± 1.3	11.8 ± 1.3
20 weeks	10.55 ± 0.8	10.7 ± 1.2

Values are means ± SD. *Values in SFO are significantly different from CA